The Biomedical Scientist magazine explores how the Greater Manchester Diagnostics Network is transforming pathology. With 54% of their cellular pathology now digitised, the programme is delivering faster diagnoses, integrating AI, and streamlining workflows to benefit both patients and staff. https://bit.ly/3VmHrsy
Institute of Biomedical Science’s Post
More Relevant Posts
-
Have you got your latest issue of The Biomedical Scientist yet? 👀 We're excited to share this fantastic feature with the Institute of Biomedical Science where our Programme Lead, Beth Tumilty explores the journey with Digital Pathology across the region and the progress to date. Have a read of the article below. ⬇️
The Biomedical Scientist magazine explores how the Greater Manchester Diagnostics Network is transforming pathology. With 54% of their cellular pathology now digitised, the programme is delivering faster diagnoses, integrating AI, and streamlining workflows to benefit both patients and staff. https://bit.ly/3VmHrsy
To view or add a comment, sign in
-
-
Recently, my perspective has shifted, AI tools have become so intuitive that doctors don’t need to be tech experts anymore. They can focus on their specialty while getting a boost from their silicon-based assistant. It’s amazing how intuitive these tools are becoming! Take Modella AI’s #digitalpathology decision support software, for example. With its ChatGPT-style interface, it feels familiar and easy to use, making AI a natural part of the workflow. I’m curious how pathologists feel about integrating tools like this into their workflow. At the end of the day, #adoption always speaks louder than #opinions. Let’s see how it plays out!
🎉✨We are excited to report that PathChat™ DX, our clinical-grade, generative AI co-pilot for pathology, has officially received Breakthrough Device Designation from the FDA! This marks a pivotal step forward in our quest to transform biomedicine with generative and agentic AI.🌟🚀 📖 Read our press release: https://lnkd.in/e9rymEC6 🎥 See our latest demo for PathChat™ 2a below 👇 📄 Read the PathChat™ article in Nature: https://lnkd.in/ea8SmfgV We’re excited to continue pushing the boundaries of innovation in healthcare! #DigitalPathology #ComputationalPathology #AI4Pathology #pathology #ai
To view or add a comment, sign in
-
🎉✨We are excited to report that PathChat™ DX, our clinical-grade, generative AI co-pilot for pathology, has officially received Breakthrough Device Designation from the FDA! This marks a pivotal step forward in our quest to transform biomedicine with generative and agentic AI.🌟🚀 📖 Read our press release: https://lnkd.in/e9rymEC6 🎥 See our latest demo for PathChat™ 2a below 👇 📄 Read the PathChat™ article in Nature: https://lnkd.in/ea8SmfgV We’re excited to continue pushing the boundaries of innovation in healthcare! #DigitalPathology #ComputationalPathology #AI4Pathology #pathology #ai
To view or add a comment, sign in
-
✍️ As part of our blog series, 'From Slides to Devices,' Professor Sabourin discusses Owkin’s pilot program with CHU de Rouen and shares his interests in the digital transition and development of AI in pathology. Learn more https://lnkd.in/e6gyYTxv
To view or add a comment, sign in
-
-
PathAI CEO recently shared his thoughts about the future of #AI and #clinicaldevelopment. Meet our wonderful CEO and get to know more about Andy's journey!
PathAI CEO, Andrew Beck was recently quoted in the #AACR journal #CancerDiscovery, discussing #foundationmodels in pathology. As quoted, Andy shares how the effectiveness of #AI tools in #pathology depends on the infrastructure and implementation surrounding them; also sharing that most valuable tools are those that are well-integrated into clinical workflows, aiding decision-making and reducing clinician workload. Andy is a trained pathologist and in 2016 he founded PathAI with the vision of transforming #digitalpathology by utilizing the latest AI tools to enable more efficient pathology workflows and reduce the workload of pathologists to transform #drugdevelopment, #diagnostics, and more. Read more about Andy and our mission at PathAI: https://lnkd.in/eWhhgwZW
To view or add a comment, sign in
-
-
PathAI CEO, Andrew Beck was recently quoted in the #AACR journal #CancerDiscovery, discussing #foundationmodels in pathology. As quoted, Andy shares how the effectiveness of #AI tools in #pathology depends on the infrastructure and implementation surrounding them; also sharing that most valuable tools are those that are well-integrated into clinical workflows, aiding decision-making and reducing clinician workload. Andy is a trained pathologist and in 2016 he founded PathAI with the vision of transforming #digitalpathology by utilizing the latest AI tools to enable more efficient pathology workflows and reduce the workload of pathologists to transform #drugdevelopment, #diagnostics, and more. Read more about Andy and our mission at PathAI: https://lnkd.in/eWhhgwZW
To view or add a comment, sign in
-
-
💻 How are AI and digital pathology shaping the future of diagnostics? In this insightful Q&A, Michael Schubert interviews Nathan Buchbinder and Julianna Ianni to explore the transformative impact of AI in digital pathology, from today’s breakthroughs to predictions for 2025. Learn how these advancements are enhancing diagnostic precision and efficiency. 📖 Don’t miss this expert take on the innovations redefining the lab landscape: https://bit.ly/3PCwEaa What innovation in digital pathology excites you most? Share your thoughts after reading!
To view or add a comment, sign in
-
-
Just a few hours left! Chaith Kondragunta is taking the stage at #DigiPathLondon to present: "AI Solutions that Make the Business Case for Digital Pathology." Visit us at 𝗕𝗼𝗼𝘁𝗵 𝟰𝟮 to explore 𝗔𝗜𝗥𝗔𝗤𝗰 and 𝗔𝗜𝗥𝗔𝗣𝗿𝗼𝘀𝘁𝗮𝘁𝗲, our AI-powered solutions for quality control and prostate analysis. Add the session to your calendar: http://evt.to/egdgdmaiw. For any questions, write to [email protected]. Let's connect soon! #DigitalPathology #AI #HealthcareTech
To view or add a comment, sign in
-
-
🌟 January webinar by the numbers! 📚 5 Talks by renowned experts in digital pathology and AI 🌏 335 Attendees from 33 Countries joined us for this impactful event Thank you to everyone who participated and made this webinar a success! Together, we’re advancing the field of digital pathology in #Asia and across the globe. Stay tuned for upcoming webinars and events! #ASDP #ASDPWebinar #DigitalPathology #AI #GlobalCommunity
To view or add a comment, sign in
-
-
We are looking forward to exhibiting and learning at Digital Pathology & AI. If you are scheduled to be at the event, stop by booth #26 to explore the critical role of structured reporting and data analytics in the dynamic world of digital pathology. #structuredreporting #digitalpathology
To view or add a comment, sign in
-